|
EP4157466A4
(en)
|
|
USE OF EZH2 INHIBITORS TO TREAT CANCER
|
|
EP4549440A4
(en)
|
|
CLASS OF PRMT5 INHIBITORS AND THEIR USES
|
|
EP4493064A4
(en)
|
|
TREATMENT FOR DEPRESSION
|
|
EP4304586A4
(en)
|
|
SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION
|
|
EP4452943A4
(en)
|
|
SMALL MOLECULE INHIBITORS OF MAMMALIAN FUNCTION OF THE SLC6A19 GENE
|
|
EP4567038A4
(en)
|
|
NEW PRMT5 INHIBITOR AND ITS USE
|
|
EP4284801A4
(en)
|
|
Small molecule inhibitors of salt inducible kinases
|
|
EP4470548A4
(en)
|
|
USE OF BACTEROIDES FRAGILIS FOR THE ALLEVIATION AND TREATMENT OF DIARRHEA
|
|
EP4225560C0
(en)
|
|
STEAM PHASE CENTRIFUGATION CLEANING OF ADDITIVELY MANUFACTURED PARTS
|
|
EP4479977A4
(en)
|
|
SYNTHETIC GENERATION OF SPECIAL IMMUNOHISTOCHEMICAL COLORS
|
|
EP4743924A1
(en)
|
|
GENERATION AND APPLICATION OF INCORPORATIONS FOR ACCOMMODATION ITEMS
|
|
EP4559913A4
(en)
|
|
PREPARATION AND USE OF A QUINAZOLINONE DERIVATIVE AS A KINASE INHIBITOR
|
|
EP4106748A4
(en)
|
|
COMPOSITIONS AND METHODS FOR TREATING KIDNEY INJURY
|
|
EP4482522A4
(en)
|
|
ANTI-ALARMIN BINDING MOLECULES AND TREATMENT OF PNEUMONITIS
|
|
EP4264417A4
(en)
|
|
DETERMINATION OF REGISTERS NEAR MEMORY
|
|
EP4281113A4
(en)
|
|
TREATMENT OF CHRONIC PRURIGO
|
|
EP4090327C0
(en)
|
|
USE OF FXR AGONISTS FOR THE TREATMENT OF HEPATITIS D VIRUS INFECTION
|
|
EP4168001A4
(en)
|
|
USE OF ACTIVATION PROTEIN 1 (AP-1) INHIBITORS TO PREVENT ADHESIONS
|
|
EP4547679A4
(en)
|
|
COMPOSITIONS AND USES OF PSILOCYBINE AND PSILOCIN
|
|
EP4427749A4
(en)
|
|
USE OF APOMORPHINE AS A THERAPEUTIC AGENT FOR DISEASES RELATED TO NECROPTOSIS
|
|
EP4486351A4
(en)
|
|
PI3K AND PD-1 INHIBITOR POLYTHERAPY
|
|
SU161260A1
(es)
|
|
|
|
EP4138837A4
(en)
|
|
TREATMENT OF AMYLOIDOSIS
|
|
EP4269412A4
(en)
|
|
CRYSTALLINE FORM OF A CASEIN KINASE 1E INHIBITOR, PREPARATION METHOD AND USE THEREOF
|
|
EP4110368C0
(en)
|
|
TREATMENT OF LIVER FAILURE
|